EVAR - Lombard Medical, Inc.

Lombard Medical, Inc. (EVAR) is a medical technology company that develops and markets endovascular repair products for aortic diseases. The company's flagship product is the Aorfix Endovascular Stent Graft, which is used to treat abdominal aortic aneurysms.

Founded in 2002, Lombard Medical is headquartered in Irvine, California, and has operations in the United States, Europe, and Asia. The company is focused on improving patient outcomes by developing innovative, minimally invasive treatments for aortic disease.

Lombard Medical has a strong intellectual property portfolio, with over 70 issued and pending patents. The company's products have been used to treat thousands of patients worldwide, and have demonstrated excellent clinical results.

However, the company has faced financial difficulties in recent years, with declining sales and significant losses. In 2019, Lombard Medical filed for Chapter 11 bankruptcy protection, and was subsequently acquired by MicroPort Scientific Corporation. Under MicroPort's ownership, Lombard Medical has continued to develop and market its products, with a focus on expanding its presence in the global market for endovascular repair products.